BioTech Breakthrough Awards Badge[1] copy.jpg
HistoSonics Edison System Recognized With BioTech Breakthrough Award For “MedTech Innovation Of The Year”
08 nov. 2023 08h02 HE | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Nouveau Logo communiqué de presse.JPG
Theratechnologies présente à l’ID Week des données montrant que la tésamoréline réduit le tissu adipeux viscéral et l’accumulation de graisse dans le foie chez les personnes vivant avec le VIH et traitées par des inhibiteurs de l’intégrase (INSTI)
13 oct. 2023 07h30 HE | Theratechnologies
La réduction significative de l’accumulation du tissu adipeux viscéral associée aux INSTI obtenue avec la tésamoréline contraste avec l’augmentation de ce tissu observée chez les patients prenant un...
Nouveau Logo communiqué de presse.JPG
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
13 oct. 2023 07h30 HE | Theratechnologies
Significant reduction in INSTI-associated VAT accumulation with tesamorelin contrasts with VAT increase in patients taking placebo VAT accumulation observed after 12 months on...
Growth in Patient an
Growth in Patient and Medical Community Engagement in NASH Community Persists Despite Recent Regulatory Disappointment
08 juin 2023 07h19 HE | Global Liver Institute
Washington, D.C., June 08, 2023 (GLOBE NEWSWIRE) -- Today is International NASH Day, a time where healthcare experts and community members around the globe step up and raise awareness of the most...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Predicted to Register a Revenue of $1,722.7 Million and Grow at a CAGR of 10.3% Over the Estimated Timeframe 2019-2026 [180-Pages] | Released by Research Dive
12 avr. 2023 09h02 HE | Research Dive
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...
February is Rare Liver Diseases Month
Obstetric and Neonatal Professionals Must Work More Closely with Pregnant People to Identify Liver Diseases Early
01 févr. 2023 11h11 HE | Global Liver Institute
Washington, D.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) launches its third annual #RareAware campaign today to raise awareness of and build resources for liver health...
Sm-logo-resized.jpg.png
Organ Preservation Market is anticipated to reach a market value of USD 377.97 million by 2030, with a CAGR of 6.93%
24 juin 2022 11h26 HE | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 24, 2022 (GLOBE NEWSWIRE) -- The factors driving the organ preservation market are a rising geriatric population, a rise in traumatic accidents and increasing cases of...
International NASH D
International NASH Day Highlights a Common – But Unfamiliar – Liver Disease
08 juin 2022 18h04 HE | Global Liver Institute
Washington, D.C., June 08, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) calls attention to NASH by leading the 5th annual International NASH Day on June 9. The number of people with this...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Estimated to Surpass $1,722.7 Million by 2026, and Grow at a CAGR of 10.3% during the Forecast Period [180-Pages] | Confirmed by Research Dive
20 avr. 2022 09h00 HE | Research Dive
New York, USA, April 20, 2022 (GLOBE NEWSWIRE) -- Research Dive states that the global cancer stem cells market is estimated to garner a revenue of $1,722.7 million by 2026, and rise at a CAGR of...
Global Liver Institute
Global Liver Institute Launches Its Liver Health Is Public Health Initiative
30 mars 2022 11h45 HE | Global Liver Institute
Washington, D.C., March 30, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI), a patient-led liver health nonprofit operating globally, today announced the launch of its global Liver Health is...